Back

Mechanical heart valves, bioprostheses, TAVI.

19 June 2017 (11:54 - 12:12)
Organised by:
Congress Presentation Part of: Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis Atrial fibrillation (AF) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Joao Morais

Polytechnic Institute of Leiria, Leiria (Portugal)

4 More presentations in this session

Presentation thumbnail
Epidemiology of valvular atrial fibrillation and implications for stroke/thromboembolism.
Professor G. Boriani (Modena, IT)
Presentation thumbnail
Evidence for antithrombotic therapy from trials.
Professor T. Potpara (Belgrade, RS)
Slides Video
Presentation thumbnail
Evidence for antithrombotic therapy from observational cohorts.
Professor L. Fauchier (Tours, FR)
Slides Video
Presentation thumbnail
What the consensus document says.
Professor G. Lip (Liverpool, GB)

Access the full session

Session thumbnail
Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

19 June 2017 11:54 CET
You may be interested in
thumbnail
Congress Presentation
Single centre experience in 1202 biological prosthesis: a comparison between sutured, sutureless and surgical transcatheter aortic valve
27 August 2021
thumbnail
Congress Session
Acute heart failure and valvular heart disease
19 May 2025
thumbnail
Congress Session
20 years of TAVI: the remaining unmet needs
23 June 2023
thumbnail
Congress Presentation
Correlations with anatomic specimens
13 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources